(6S,8R,9S,10R,13S,14S)-10,13-dimethyl-6-(4-phenylbutyl)-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3,17(6H)-dione

ID: ALA5287563

Max Phase: Preclinical

Molecular Formula: C29H36O2

Molecular Weight: 416.61

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@]12C=CC(=O)C=C1[C@@H](CCCCc1ccccc1)C[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12

Standard InChI:  InChI=1S/C29H36O2/c1-28-16-14-22(30)19-26(28)21(11-7-6-10-20-8-4-3-5-9-20)18-23-24-12-13-27(31)29(24,2)17-15-25(23)28/h3-5,8-9,14,16,19,21,23-25H,6-7,10-13,15,17-18H2,1-2H3/t21-,23-,24-,25-,28+,29-/m0/s1

Standard InChI Key:  PPIHKQBEDCWNHL-PQQTXWEMSA-N

Molfile:  

 
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
    1.6197    4.0135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5258    3.1938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8123    3.6166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0857    3.2118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0857    2.3816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6357    1.9794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8002    2.5820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3439    2.3996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0720    1.9934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0720    1.1685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7921    0.7624    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3639    0.7484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6357    1.1506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0694    0.7318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0694   -0.0946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7852   -0.5079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7852   -1.3344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5010   -1.7476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5010   -2.5742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2159   -2.9876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2159   -3.8116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5000   -4.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7821   -3.8152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7821   -2.9892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7976    1.1378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7976    1.9629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4205    1.2788    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.5258    2.3689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3001    2.1029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7921    2.7698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3142    3.4425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5801    4.2250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8779    1.4649    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7740    2.8946    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  1
  8  6  1  0
  9  8  2  0
 10  9  1  0
 11 10  2  0
 10 12  1  0
 12 13  2  0
 13  6  1  0
 14 13  1  0
 14 15  1  6
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 20 19  2  0
 21 20  1  0
 22 21  2  0
 23 22  1  0
 24 23  2  0
 19 24  1  0
 25 14  1  0
 25 26  1  0
 26  5  1  0
 26 27  1  1
 28 26  1  0
  2 28  1  0
 29 28  1  0
 30 29  1  0
 31 30  1  0
 31  2  1  0
 32 31  2  0
 28 33  1  6
  5 34  1  6
M  END

Alternative Forms

  1. Parent:

    ALA5287563

    ---

Associated Targets(Human)

CYP19A1 Tclin Cytochrome P450 19A1 (6099 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 416.61Molecular Weight (Monoisotopic): 416.2715AlogP: 6.50#Rotatable Bonds: 5
Polar Surface Area: 34.14Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 7.13CX LogD: 7.13
Aromatic Rings: 1Heavy Atoms: 31QED Weighted: 0.51Np Likeness Score: 1.85

References

1. Adhikari N, Baidya SK, Jha T..  (2020)  Effective anti-aromatase therapy to battle against estrogen-mediated breast cancer: Comparative SAR/QSAR assessment on steroidal aromatase inhibitors.,  208  [PMID:33017749] [10.1016/j.ejmech.2020.112845]

Source